Nafadotride

Nafadotride is a drug that acts as a selective antagonist for the D3 dopamine receptor. It was developed for the treatment of Schizophrenia, but was not pursued for this application. However, it has been found to be useful in scientific research.

Pharmacology

Nafadotride is a selective antagonist for the D3 dopamine receptor. This means it binds to these receptors and blocks their activation by dopamine, a neurotransmitter that is involved in many functions including mood, reward, and motor control. By blocking the activation of D3 receptors, nafadotride can alter the effects of dopamine in the brain.

Uses

While nafadotride was initially developed for the treatment of schizophrenia, it was not pursued for this application. However, it has been found to be useful in scientific research. Because of its selective action on D3 receptors, it can be used to study the role of these receptors in various brain functions and diseases.

Side Effects

As with any drug, nafadotride can have side effects. However, because it is primarily used in research and not in clinical practice, these side effects are not well documented.

See Also

• Dopamine receptor D3
• Dopamine
• Schizophrenia

References

<references />

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia

• 
  Nafadotride